These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 15199444

  • 1. C-reactive protein and other inflammatory biomarkers as predictors of outcome following acute coronary syndromes.
    Abbate A, Biondi-Zoccai GG, Brugaletta S, Liuzzo G, Biasucci LM.
    Semin Vasc Med; 2003 Nov; 3(4):375-84. PubMed ID: 15199444
    [Abstract] [Full Text] [Related]

  • 2. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC, Lima JC, Rocha MS, D'Oliveira Junior A, Péricles Esteves J.
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic value of C-reactive protein and troponin T level in patients with unstable angina pectoris].
    Tanaka H, Tsurumi Y, Kasanuki H.
    J Cardiol; 2006 Apr; 47(4):173-9. PubMed ID: 16637251
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.
    Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Bertrand F, Dagenais GR, Brophy JM.
    J Am Coll Cardiol; 2008 Jun 17; 51(24):2339-46. PubMed ID: 18549920
    [Abstract] [Full Text] [Related]

  • 6. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes.
    Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, Zeiher AM, CAPTURE Study Investigators.
    Circulation; 2003 Apr 29; 107(16):2109-14. PubMed ID: 12668510
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. How to use the C-reactive protein in cardiac disease?
    Ursella S, Mazzone M, Portale G, Testa A, Pignataro G, Covino M, Fenici P, Gasbarrini GB, Gentiloni Silveri N.
    Minerva Cardioangiol; 2005 Feb 29; 53(1):59-68. PubMed ID: 15788980
    [Abstract] [Full Text] [Related]

  • 10. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
    Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Simoons ML, Zeiher AM, CAPTURE Study Investigators.
    J Am Coll Cardiol; 2005 Jan 18; 45(2):229-37. PubMed ID: 15653020
    [Abstract] [Full Text] [Related]

  • 11. Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine.
    Bodí V, Sanchis J, Llàcer A, Fácila L, Núñez J, Bertomeu V, Pellicer M, Chorro FJ.
    Int J Cardiol; 2005 Feb 15; 98(2):277-83. PubMed ID: 15686779
    [Abstract] [Full Text] [Related]

  • 12. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD, Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators.
    Circulation; 2004 Nov 16; 110(20):3206-12. PubMed ID: 15533869
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.
    Indian Heart J; 2008 Nov 16; 60(6):536-42. PubMed ID: 19276492
    [Abstract] [Full Text] [Related]

  • 16. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
    Jahn J, Hellmann I, Maass M, Giannitsis E, Dalhoff K, Katus HA.
    Herz; 2004 Dec 16; 29(8):795-801. PubMed ID: 15599677
    [Abstract] [Full Text] [Related]

  • 17. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
    Foussas SG, Zairis MN, Lyras AG, Patsourakos NG, Tsirimpis VG, Katsaros K, Beldekos DJ, Handanis SM, Mytas DZ, Karidis KS, Tselioti PG, Prekates AA, Ambrose JA.
    Am J Cardiol; 2005 Aug 15; 96(4):533-7. PubMed ID: 16098307
    [Abstract] [Full Text] [Related]

  • 18. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, Vicente V, Lip GY.
    J Intern Med; 2007 Dec 15; 262(6):651-8. PubMed ID: 17986200
    [Abstract] [Full Text] [Related]

  • 19. Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease.
    Biasucci LM, Liuzzo G, Colizzi C, Rizzello V.
    Ital Heart J; 2001 Mar 15; 2(3):164-71. PubMed ID: 11305527
    [Abstract] [Full Text] [Related]

  • 20. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS, Tzontcheva AV, Kehayov I, Finkov B.
    Clin Biochem; 2008 Feb 15; 41(3):126-33. PubMed ID: 18061588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.